JP2013514778A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514778A5
JP2013514778A5 JP2012544863A JP2012544863A JP2013514778A5 JP 2013514778 A5 JP2013514778 A5 JP 2013514778A5 JP 2012544863 A JP2012544863 A JP 2012544863A JP 2012544863 A JP2012544863 A JP 2012544863A JP 2013514778 A5 JP2013514778 A5 JP 2013514778A5
Authority
JP
Japan
Prior art keywords
human
chain gene
gamma
mouse
alpha chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012544863A
Other languages
English (en)
Japanese (ja)
Other versions
JP5595517B2 (ja
JP2013514778A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/060925 external-priority patent/WO2011084664A1/en
Publication of JP2013514778A publication Critical patent/JP2013514778A/ja
Publication of JP2013514778A5 publication Critical patent/JP2013514778A5/ja
Application granted granted Critical
Publication of JP5595517B2 publication Critical patent/JP5595517B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012544863A 2009-12-21 2010-12-17 ヒト化FcγRマウス Active JP5595517B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28856209P 2009-12-21 2009-12-21
US61/288,562 2009-12-21
PCT/US2010/060925 WO2011084664A1 (en) 2009-12-21 2010-12-17 HUMANIZED FCγ R MICE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014087973A Division JP5891259B2 (ja) 2009-12-21 2014-04-22 ヒト化FcγRマウス

Publications (3)

Publication Number Publication Date
JP2013514778A JP2013514778A (ja) 2013-05-02
JP2013514778A5 true JP2013514778A5 (enExample) 2014-02-13
JP5595517B2 JP5595517B2 (ja) 2014-09-24

Family

ID=43601078

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012544863A Active JP5595517B2 (ja) 2009-12-21 2010-12-17 ヒト化FcγRマウス
JP2014087973A Active JP5891259B2 (ja) 2009-12-21 2014-04-22 ヒト化FcγRマウス
JP2014165102A Active JP6073840B2 (ja) 2009-12-21 2014-08-14 ヒト化FcγRマウス
JP2016030271A Pending JP2016093201A (ja) 2009-12-21 2016-02-19 ヒト化FcγRマウス

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2014087973A Active JP5891259B2 (ja) 2009-12-21 2014-04-22 ヒト化FcγRマウス
JP2014165102A Active JP6073840B2 (ja) 2009-12-21 2014-08-14 ヒト化FcγRマウス
JP2016030271A Pending JP2016093201A (ja) 2009-12-21 2016-02-19 ヒト化FcγRマウス

Country Status (26)

Country Link
US (9) US8658154B2 (enExample)
EP (3) EP3498730B1 (enExample)
JP (4) JP5595517B2 (enExample)
KR (4) KR101862277B1 (enExample)
CN (2) CN102762590B (enExample)
AU (3) AU2010339863B2 (enExample)
CA (2) CA3000246C (enExample)
CY (1) CY1120316T1 (enExample)
DK (1) DK2516457T3 (enExample)
ES (1) ES2671188T3 (enExample)
HK (1) HK1257001A1 (enExample)
HR (1) HRP20180911T1 (enExample)
HU (1) HUE038684T2 (enExample)
IL (4) IL220365A (enExample)
LT (1) LT2516457T (enExample)
MY (1) MY156743A (enExample)
NO (1) NO2516457T3 (enExample)
PL (1) PL2516457T3 (enExample)
PT (1) PT2516457T (enExample)
RS (1) RS57280B1 (enExample)
RU (1) RU2549695C2 (enExample)
SG (3) SG10201408415PA (enExample)
SI (1) SI2516457T1 (enExample)
SM (1) SMT201800296T1 (enExample)
TR (1) TR201808011T4 (enExample)
WO (1) WO2011084664A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2516457T3 (enExample) 2009-12-21 2018-08-11
RU2634417C2 (ru) 2011-10-28 2017-10-26 Регенерон Фармасьютикалс, Инк. Гуманизированные il-6 и рецептор il-6
US20160058891A1 (en) * 2011-11-01 2016-03-03 Roche Glycart Ag In vivo adcc model
EP3939423B1 (en) * 2012-11-05 2024-03-06 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals and methods of use thereof
EP3842528A1 (en) 2013-09-18 2021-06-30 Kymab Limited Methods, cells and organisms
RU2674910C2 (ru) * 2013-10-15 2018-12-13 Регенерон Фармасьютикалс, Инк. Животные с гуманизированным геном il-15
MX388127B (es) 2013-12-11 2025-03-19 Regeneron Pharma Metodos y composiciones para la modificacion dirigida de un genoma.
KR102846903B1 (ko) * 2014-03-21 2025-08-20 리제너론 파마슈티칼스 인코포레이티드 단일 도메인 결합 단백질을 생산하는 비-인간 동물
HUE051088T2 (hu) 2014-04-08 2021-03-01 Regeneron Pharma Humanizált FC-gamma receptorokkal rendelkezõ nem humán élõlények
CN111118047B (zh) 2014-05-30 2023-09-22 再生元制药公司 人源化二肽基肽酶iv(dpp4)动物
LT3230320T (lt) * 2014-12-09 2021-01-11 Regeneron Pharmaceuticals, Inc. Gyvūnai, išskyrus žmogų, turintys humanizuotą diferenciacijos klasterio 274 geną
FI3282835T3 (fi) * 2015-04-13 2023-07-20 Regeneron Pharma Humanisoituja sirpa-il15-poistogeenisiä hiiriä ja niiden käyttömenetelmiä
CN107529739B (zh) * 2015-04-30 2021-01-08 株式会社特殊免疫研究所 表达人特定分子和人Fcγ受体家族的转基因非人动物
CN113831407B (zh) 2016-05-20 2024-06-11 瑞泽恩制药公司 用于使用多个引导rna来破坏免疫耐受性的方法
US11879014B2 (en) * 2017-03-17 2024-01-23 Tusk Therapeutics Ltd. Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody
KR20250121150A (ko) 2018-03-26 2025-08-11 리제너론 파마슈티칼스 인코포레이티드 치료제를 시험하기 위한 인간화된 설치류
JP6935383B2 (ja) 2018-09-27 2021-09-15 公益財団法人実験動物中央研究所 免疫不全マウス
EP3861854B1 (en) * 2018-09-27 2025-01-22 Central Institute for Experimental Medicine and Life Science Immunodeficient mouse
SG11202107589PA (en) 2019-02-22 2021-08-30 Regeneron Pharma Rodents having genetically modified sodium channels and methods of use thereof
CN113614238B (zh) * 2019-03-28 2024-10-22 公益财团法人实中研 免疫缺陷小鼠
KR20230147048A (ko) 2020-12-16 2023-10-20 리제너론 파마슈티칼스 인코포레이티드 인간화 Fc 알파 수용체를 발현하는 마우스
CN114410643B (zh) * 2021-02-02 2024-08-02 百奥赛图(北京)医药科技股份有限公司 FcRn基因人源化的非人动物及其构建方法和应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929256T2 (de) 1988-05-27 2001-05-17 Applied Research Systems Ars Holding N.V., Curacao Humaner Rezeptor Fc(gamma)RIII
JP2938569B2 (ja) * 1990-08-29 1999-08-23 ジェンファーム インターナショナル,インコーポレイティド 異種免疫グロブリンを作る方法及びトランスジェニックマウス
US5258359A (en) * 1991-08-02 1993-11-02 Monsanto Company Glyphosant-containing herbicidal compositions comprising acetylenic diol rainfastness enhancing agents
WO1994006908A1 (en) 1992-09-11 1994-03-31 The Regents Of The University Of California Transgenic non-human animals having targeted lymphocyte transduction genes
US5877396A (en) 1993-04-23 1999-03-02 Sloan Kettering Institute For Cancer Research Mice mutant for functional Fc receptors and method of treating autoimmune diseases
US6111166A (en) * 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
CA2273194C (en) 1996-12-03 2011-02-01 Abgenix, Inc. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
US5899312A (en) * 1997-07-22 1999-05-04 Lucent Technologies Inc Anti-fraud string grabbing device
US6676927B1 (en) 1999-01-20 2004-01-13 The Rockefeller University Animal model and methods for its use in the selection of cytotoxic antibodies
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
JP2003531149A (ja) 2000-04-13 2003-10-21 ザ・ロツクフエラー・ユニバーシテイ 抗体由来の免疫応答の増強
CN101498731A (zh) * 2000-05-18 2009-08-05 日本烟草产业株式会社 抗协同刺激信号转导分子ailim的人单克隆抗体及其药物用途
US7413031B2 (en) 2000-07-18 2008-08-19 The Charles Machine Works, Inc. Apparatus and method for maintaining control of a drilling machine
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
FR2822161B1 (fr) 2001-03-15 2003-09-19 Genoway Cellule et animal transgenique modelisant les reponses humaines allergiques mediees par les ige, et leurs utilisations
JP4653915B2 (ja) 2001-10-29 2011-03-16 独立行政法人科学技術振興機構 全身性エリテマトーデスモデル非ヒト動物
US20040132101A1 (en) * 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
WO2003104459A1 (en) 2002-06-07 2003-12-18 Arthron Limited Fcyriia transgenic animal model for autoimmune disease
JP2004147535A (ja) 2002-10-29 2004-05-27 Japan Science & Technology Agency ギラン・バレー症候群及び/又はフィッシャー症候群発症モデル非ヒト動物
WO2004060053A2 (en) * 2002-12-16 2004-07-22 Genentech, Inc. Transgenic mice expressing human cd20
FR2858235B1 (fr) 2003-07-31 2006-02-17 Lab Francais Du Fractionnement Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs
BRPI0506771A (pt) * 2004-01-12 2007-05-22 Applied Molecular Evolution anticorpo, e, composição farmacêutica
DK1802193T3 (da) 2004-10-19 2014-06-10 Regeneron Pharma Fremgangsmåde til frembringelse af en homozygot mus til genetisk modifikation
WO2007041635A2 (en) * 2005-10-03 2007-04-12 Xencor, Inc. Fc variants with optimized fc receptor binding properties
SG170110A1 (en) 2006-03-10 2011-04-29 Macrogenics Inc Identification and engineering of antibodies with variant heavy chains and methods of using same
US20080003225A1 (en) 2006-06-29 2008-01-03 Henri Vie Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
EP2066349B1 (en) * 2006-09-08 2012-03-28 MedImmune, LLC Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases
HU0700534D0 (en) * 2006-11-24 2007-10-29 Mezoegazdasagi Biotechnologiai Transgenic animal with enhanced immune response and method for the preparation thereof
KR101561020B1 (ko) 2007-07-31 2015-10-26 리제너론 파아마슈티컬스, 인크. 사람 cd20에 대한 사람 항체 및 이의 사용 방법
EP2245155A4 (en) * 2007-12-10 2011-05-25 Aliva Biopharmaceuticals Inc METHODS FOR SEQUENTIALLY REPLACING A TARGETED AREA BY HOMOLOGOUS RECOMBINATION
US20090271884A1 (en) 2008-03-07 2009-10-29 Regeneron Pharmaceuticals, Inc. ES Cell-Derived Mice From Diploid Host Embryo Injection
EP2318439A2 (en) * 2008-07-23 2011-05-11 Rappaport Family Institute for Research in the Medical Sciences Methods of altering peripheral b cell populations and uses thereof
NO2516457T3 (enExample) * 2009-12-21 2018-08-11
US8883496B2 (en) * 2009-12-21 2014-11-11 Regeneron Phamaceuticals, Inc. Humanized FcgR mice

Similar Documents

Publication Publication Date Title
JP2013514778A5 (enExample)
RU2012131296A (ru) ГУМАНИЗИРОВАННЫЕ Fc ГАММА R МЫШИ
CN113016720B (zh) 表达人源化cd3复合物的非人类动物
RU2700484C2 (ru) Не относящиеся к человеку животные, имеющие гуманизированные fc-гамма-рецепторы
JP7731359B2 (ja) ヘテロ二量体Fcポリペプチド
US9221894B2 (en) Isolated cells from humanized FcγR mice
HK40009391A (en) Humanized fc gamma r mice
HK1171033B (en) Humanized fc gamma r mice